How have the shares performed?
Treace Medical Concepts Inc. (TMCI) saw downtrend of -3.73% in the recent trading with $31.50 being its most recent. The current price level -15.25% lower than the highest price of $37.17 marked by the stock while trading over the past 52-weeks, whereas it is 29.90% higher than the lowest price of $24.25 the company dropped to over past 52-weeks. The latest news story on TMCI appeared in GlobeNewswire under the title “Treace Medical Concepts Reports First Quarter 2021 Financial Results” on May-25-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -15.25% below one month high and is +12.78% above of the lowest during that time.
Treace Medical Concepts Inc. Earnings – What Happened With TMCI
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. During the reported three-month period, company’s sales were $18.71 billion.
TMCI – Treace Medical Concepts Inc. Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 54.77 million. TMCI does have institutional investors; and they hold 5.14% of the stock.
Treace Medical Concepts Inc. – Insider Activity and Holdings
Moreover, the latest SEC filings also revealed that stock came across 14 new insider purchases involving 3,681,891 shares. On the other hand, TMCI declared 5,984,285 shares have been sold in 3 insider transactions over the past three months.
As on Apr 29, 2021, AB Cap Fd.-AB Small Cap Growth Port was the top most holder in Treace Medical Concepts Inc. (NASDAQ:TMCI) with an ownership of 1.03 million shares of the company or 1.96% of the stake worth $32.38 million. The filing also reveals Fidelity Growth Company Fund as the second largest holder in the company with a control over 0.48% of the outstanding shares. Its stake is worth $8.01 million for having 0.26 million shares in hand.
PGIM Jennison Health Sciences Fd also came holding a key position in the company during the recent quarter and it now holds 0.28% of the outstanding shares. With this there are now 15 institutions which have possession in TMCI’s shares.